Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

 

Search in our Online Store

Generics
Filter     Order     Display # 
Date Item Title
04 Aug 2007 Abraxis BioScience Receives FDA Approval for Caffeine Citrate Injection USP, 20 mg/mL
21 Jul 2007 Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Provigil(R)
20 Jul 2007 Abraxis BioScience and Biocon Limited Announce Licensing Agreement for G-CSF in North America and the European Union
18 Jul 2007 Akorn-Strides, LLC Announces its First ANDA Approval For Keterolac Tromethamine Injection USP, 15 mg/mL and 30 mg/mL
12 Jul 2007 Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Tenormin(R)
11 Jul 2007 Ranbaxy receives final US FDA approval to manufacture and market Amlodipine Besylate tablets
04 Jul 2007 Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Paxil(R)
04 Jul 2007 Teva Announces Approval Of Terbinafine Hcl Tablets
04 Jul 2007 Aurobindo received 46th ANDA approval
04 Jul 2007 Taro Receives Final Approval for Terbinafine HCL Cream 1% ANDA
04 Jul 2007 Glenmark receives US FDA approval for Terbinafine Hydrochloride tablets
03 Jul 2007 Mylan Announces Final FDA Approval for Terbinafine Hydrochloride Tablets
02 Jul 2007 Teva Announces Approval Of Amlodipine Besylate Tablets
30 Jun 2007 Glenmark receives US FDA approval for Ondansetron IR and Ondansetron ODT tablets
29 Jun 2007 INVEGA(TM) Receives Marketing Authorization In European Union For Treatment Of Schizophrenia
29 Jun 2007 Pfizer Initiates Phase III Trial to Study Sunitinib Malate in Patients with Metastatic Colorectal Cancer
29 Jun 2007 Teva Announces Tentative Approval Of Famciclovir Tablets
26 Jun 2007 Mylan Announces Final FDA Approval for Ondansetron Hydrochloride Tablets and Ondansetron Orally Disintegrating Tablets, USP
25 Jun 2007 Barr Receives Approval for Generic VESANOID(R) Capsules, 10 mg
23 Jun 2007 Ranbaxy receives tentative approval from us FDA for Tamsulosin capsules
23 Jun 2007 Sandoz receives positive EU opinion for approval of epoetin alfa biosimilar
22 Jun 2007 Glenmark receives tentative US FDA approval for its ANDA for Terbinafine HCL tablets
21 Jun 2007 Ranbaxy receives tentative approval to manufacture and market amlodipine besylate tablets
21 Jun 2007 Wockhardt to launch Cefprozil, in the US, Eight FDA approval in 4 months
16 Jun 2007 Aurobindo gets USFDA Approval for Trandolapril Tablets
15 Jun 2007 Lupin Pharmaceuticals, Inc. Announces Final Approval of Trandolapril Tablets
14 Jun 2007 Watson Receives FDA Final Approval for Generic Wellbutrin XL(R) 300 Mg
13 Jun 2007 IBPL Becomes Country's First Dedicated Biopharmaceutical Facility to Receive EU-GMP Certification
09 Jun 2007 Mylan Announces Final FDA Approval for Doxycycline Tablets, 150mg
01 Jun 2007 Wockhardt gets US FDA nod to enter the $680 million Lamisil market
01 Jun 2007 Mylan Announces Final FDA Approval for Azithromycin Tablets
01 Jun 2007 Mylan Announces Tentative FDA Approval for Paroxetine Hydrochloride Extended-Release Tablets
31 May 2007 IMPAX Receives Final FDA Approval for Generic Xanax(R) XR Extended Release Tablets
31 May 2007 Mylan Announces Final FDA Approval for Fluoxetine Capsules USP, 40 mg
30 May 2007 Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec(R)
23 May 2007 Lupin Pharmaceuticals, Inc. Receives US FDA Approval for Ziprasidone HCl Capsules
22 May 2007 Sandoz Receives FDA Approval for Generic Toprol XL(R) 50 mg Tablet
19 May 2007 KV Pharmaceutical Company (KVA) Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
17 May 2007 Glenmark receives US FDA approval to market generic
17 May 2007 Ranbaxy Receives Tentative FDA Approval for Fexofenadine Hydrochloride Tablets
16 May 2007 Lupin Pharmaceuticals, Inc. Receives US FDA Approval for Simvastatin Tablets
11 May 2007 Teva Announces Approval and Shipment of Generic Omnicef(R) Capsules and POS
09 May 2007 Lupin Pharmaceuticals, Inc. Announces Final FDA Approval of Cefdinir for Oral Suspension, 250 mg/5 mL, Launches Entire Product Family
09 May 2007 Inspire Announces Positive Results of Phase 2 Trial of Epinastine Nasal Spray for Seasonal Allergic Rhinitis
04 May 2007 Mylan Announces Tentative FDA Approval for Letrozole Tablets, USP
03 May 2007 Barr Laboratories (BRL) Receives Approval for Generic Nimotop(R) Capsules, 30 mg
01 May 2007 Dr. Reddy's launches Reditux(TM) Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma
27 Apr 2007 Ranbaxy Receives Final Us FDA Approval to Manufacture and Market Zolpidem Tablets in Usa
26 Apr 2007 Dr. Reddy's Announces the Launch of Zolpidem Tartrate Tablets
26 Apr 2007 Ranbaxy Receives Us Fda Approval To Manufacture And Market Pravastatin Sodium Tablets In Usa
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >>
Results 151 - 200 of 408

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Thrombopoiesis-Stimulating Agents (TPO)

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics